As tick season worsens each year in the Northeast and cases of Lyme disease trend upward, researchers at the UMass Chan ...

An international team of scientists has generated a new ring-shaped protein nanomaterial capable of strongly binding to and ...

The global Cancer Biological Therapy Market is entering a transformative decade, fueled by breakthroughs in precision ...

The Chronic Lymphocytic Leukemia Market is set for significant expansion over the next decade. Valued at USD 5.4 billion in 2025, the market is projected to grow to USD 10.3 billion by 2035, ...

THIRUVANANTHAPURAM: Taking a significant step forward in haemophilia care, the health department is set to establish a comprehensive centre dedicated to patients with bleeding disorders. This tertiary ...

A promising new treatment for Lyme disease, a condition transmitted through tick bites, is in development and aims to offer ...

Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.

Hospitalizations due to RSV cases in infants are reduced by up to 43% following the introduction of new maternal vaccines.

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

The FDA has granted Fast Track designation to Bristol Myers Squibb’s anti-MTBR-tau antibody (BMS-986446) for the treatment of early Alzheimer disease.

JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended receptor occupancy with the goal of delivering deeper, more durable B cell ...